Nature of Human Gut Microbiome: How do they play in Cardiovascular Disease?

Main Article Content

Han Naung Tun*

Abstract

Cardiovascular disease is the number one killer of death around the world. Most of the cardiovascular diseases are caused by sedentary life style, bad eating habit, tobacco smoking, high alcohol intake, dyslipidemia and genetic factors .Recently the idea of human microbiome science has emerged in diseases pathogenesis .The human gut is a house of trillions of microbial floral. Since a couple of decades ago, there has been interesting insights into the human gut microbiota and have highlighted its increasingly association to cardiovascular (CV) and metabolic diseases. Trimethylamine N-oxide (TMAO), which is a metabolic product from gut microbiota plays a central role in cardiovascular disease pathogenesis. Nature of microbial inhabitants within the host has been noticed by the numbers of scientists and researchers to understand more about the hidden mechanism of diseases pathogenesis including cardiovascular disease, metabolic and autoimmune diseases and it has become a good hope to develop new drug designs to prevent metabolic and cardiovascular disease in near future.

Downloads

Download data is not yet available.

Article Details

Tun, H. N. (2018). Nature of Human Gut Microbiome: How do they play in Cardiovascular Disease?. Journal of Cardiovascular Medicine and Cardiology, 5(4), 064–066. https://doi.org/10.17352/2455-2976.000074
Review Articles

Copyright (c) 2018 Tun HN.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Ursell LK, Metcalf JL, Parfrey LW, Knight R (2012) Defining the human microbiome. Nutr Rev 70: 38-44. Link: https://goo.gl/3DKvGA

Ana M Valdeand (2018) Role of the gut microbiota in nutrition and health BMJ 2018; 361. Link: https://goo.gl/FDAtCB

Janssens Y, Antoon Bronselaer JN, Debunne N (2018) Disbiome database: linking the microbiome to disease BMC Microbiology 18: 50. Link: https://goo.gl/GnHFrG

Tang WH, Hazen SL (2014) The contributory role of gut microbiota in cardiovascular disease. J Clin Invest 124: 4204-11. Link: https://goo.gl/bqt599

Liang D, Ka-Kit Leung R, Guan W, Au WW (2018) Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities J of Gut Pathogen. Link: https://goo.gl/c3552C

Wilson Tang WH, Kitai T, Hazen SL (2017) Gut Microbiota in Cardiovascular Health and Disease, Circulation Research 120:1183–1196. Link: https://goo.gl/eJdQrD

Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, et al. (2015) Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med 277: 717-26. Link: https://goo.gl/uXHKc1

Romano KA, Vivas EI, Amador-Noguez D, Rey FE, (2015) Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio 6: e02481. Link: https://goo.gl/BJ36yE

Kim Y, Keogh J, Clifton PA (2015) review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus. Metabolism 64: 768-79. Link: https://goo.gl/Un8rVT

Baohon gWang, Mingfei Yao (2017) The Human Microbiota in Health and Disease, Microecology 71-82.

Baker JR, Chaykin S (1962) "The biosynthesis of trimethylamine-N-oxide". J. Biol. Chem 237: 1309–1313. Link: https://goo.gl/xazn6F

Wang Z, Klipfell E, Bennett BJ (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-63. Link: https://goo.gl/nAw1DV

Zhu W, Gregory JC, Org E (2016) Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165: 111–124. Link: https://goo.gl/4UcamN

Dambrova M, Latkovskis G (2016) Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels. xp Clin Endocrinol Diabetes 124: 251-6. Link: https://goo.gl/Gx4j1J

Heianza Y, Wenjie Ma (2017) Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies. Journal of the American Heart Association 6: e004947. Link: https://goo.gl/vZ5srD

Roberts AB (2018) Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential, Nature Medicine. Link: https://goo.gl/kaNXkt